title: Pro/Con debate of activated protein C in severe sepsis.
authors.forename: J C A
authors.initials: JC
authors.lastname: Joore
authors.forename: H J
authors.initials: HJ
authors.lastname: van Leeuwen
authors.forename: J
authors.initials: J
authors.lastname: Meulenbelt
authors.forename: T J M
authors.initials: TJ
authors.lastname: Tobé
authors.forename: J W
authors.initials: JW
authors.lastname: Fijen
authors.forename: J W
authors.initials: JW
authors.lastname: Figen
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D011486:Protein C / Q000191:economics / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012720:Severity of Illness Index
chemical_list: D011486:Protein C